VERTEX PHARMACEUTICALS INC / MA Accounts Payable 2009-2026 | VRTX
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is VERTEX PHARMACEUTICALS INC / MA's current accounts payable?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual accounts payable for 2025 was $461.7M, a 11.79% increase from 2024. VERTEX PHARMACEUTICALS INC / MA accounts payable for the quarter ending March 31, 2026 was $489.3M.
What was VERTEX PHARMACEUTICALS INC / MA's accounts payable in 2024?
VERTEX PHARMACEUTICALS INC / MA annual accounts payable for 2024 was $413.0M, a 13.18% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's accounts payable in 2023?
VERTEX PHARMACEUTICALS INC / MA annual accounts payable for 2023 was $364.9M, a 20.07% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year accounts payable CAGR?
VERTEX PHARMACEUTICALS INC / MA accounts payable grew at a compound annual growth rate (CAGR) of 24.38% from FY2020 to FY2025, going from $155.1M to $461.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $461.7M | +11.8% | 10-K |
| FY2024 | $413.0M | +13.2% | 10-K |
| FY2023 | $364.9M | +20.1% | 10-K |
| FY2022 | $303.9M | +55.8% | 10-K |
| FY2021 | $195.0M | +25.7% | 10-K |
| FY2020 | $155.1M | +77.0% | 10-K |
| FY2019 | $87.6M | -21.1% | 10-K |
| FY2018 | $111.0M | +50.0% | 10-K |
| FY2017 | $74.0M | +20.4% | 10-K |
| FY2016 | $61.5M | -18.0% | 10-K |
| FY2015 | $74.9M | +5.3% | 10-K |
| FY2014 | $71.2M | +44.3% | 10-K |
| FY2013 | $49.3M | -51.3% | 10-K |
| FY2012 | $101.3M | +35.7% | 10-K |
| FY2011 | $74.6M | +108.2% | 10-K |
| FY2010 | $35.9M | -3.1% | 10-K |
| FY2009 | $37.0M | - | 10-K |